Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,662,680,977
+$1,416,578,500 QoQ
Shares Held
3,347,253
+507.3% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#12
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. VRTX ranks #2 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,662,680,977 | 3,347,253 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $246,102,477 | 551,132 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $249,620,010 | 550,600 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $181,311,299 | 462,954 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $233,210,445 | 523,833 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $340,360,117 | 702,034 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $306,260,190 | 760,517 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $221,765,486 | 476,833 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $258,927,486 | 552,414 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $293,885,689 | 703,059 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $273,608,293 | 672,438 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $262,378,168 | 754,524 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $292,626,531 | 831,538 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $240,684,804 | 763,909 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $228,706,535 | 791,975 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $270,097,674 | 932,851 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $279,242,331 | 990,959 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $293,527,569 | 1,124,756 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $232,622,497 | 1,059,301 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $157,251,339 | 866,924 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $225,502,382 | 1,118,397 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $250,062,546 | 1,163,677 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $302,533,395 | 1,280,077 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $324,873,179 | 1,193,860 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $331,736,364 | 1,142,697 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $259,792,617 | 1,091,795 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||